Marion B.
- Country
- France
- Department
- Médecine A - Gastroentérologie
Research Overview
- PRODIGE 81-FFCD 2101-TRIPLET: Randomized, open-label, phase II-III study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patients with hepatocellular carcinoma receiving first-line systemic therapy
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
- Comparison of mFOLFIRINOX Versus Platinum-Etoposide in First-Line Chemotherapy for Metastatic Grade 3 Gastroenteropancreatic Neuroendocrine Carcinoma
Data & Insights
Has run more than one trial at 109 of 178 partner sites.
Specializations
Colorectal Cancer Research
Specializes in investigating innovative approaches for stage III colorectal cancer treatment, with particular focus on minimal residual disease detection through ctDNA analysis. The investigator explores advanced therapeutic strategies for both early-stage and metastatic colorectal cancer.
- Post-surgical treatment optimization
- Circulating tumor DNA monitoring
- Metronomic chemotherapy approaches
Demonstrates expertise in geriatric oncology through studies of neoadjuvant chemotherapy in elderly patients with colon cancer.
Hepatobiliary Oncology
Conducts research in advanced treatments for hepatocellular carcinoma and biliary tract carcinoma. Focuses on innovative immunotherapy combinations and adjuvant therapy approaches.
- Immunotherapy combinations
- Post-resection adjuvant therapy
- Novel therapeutic strategies
Investigates targeted treatments incorporating immune checkpoint inhibitors and anti-angiogenic agents.
Pancreatic Cancer
Focuses on developing treatment strategies for pancreatic adenocarcinoma, particularly in patients requiring alternative approaches to standard protocols.
- First-line metastatic treatment
- Alternative chemotherapy regimens
- Patient-specific treatment approaches
Specializes in evaluating modified chemotherapy protocols for patients unsuitable for conventional treatment regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.